Geoffrey Lynn
Company: Barinthus Biotherapeutics
Job title: Senior Vice President - Synthetic Immunotherapies
Seminars:
New insights into the MOA for systemic tolerance induction with IM administered SNAP-TI nanoparticles and updates on the clinical candidate VTP-1000 9:00 am
day: Custom Day Two